Company News: Page (1) of 1 - 01/04/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook

InflaRx to Present at Upcoming Investor Conferences

(January 04, 2018)

DGAP-News: InflaRx N.V. / Key word(s): Conference

04.01.2018 / 19:15
The issuer is solely responsible for the content of this announcement.


InflaRx to Present at Upcoming Investor Conferences

Jena, Germany, January 4, 2018 - InflaRx N.V. (Nasdaq:IFRX), the biopharmaceutical company developing new therapeutics in the terminal complement space, will present at the following conferences:

J.P. Morgan Annual Healthcare Conference
Date: January 8-11, 2018,
Presentation: Wed, 10th Jan 8:00 am PST (5:00 pm CET)
Venue: San Francisco, CA, USA
Presenter: Prof. Niels Riedemann, Chief Executive Officer of InflaRx
Arnd Christ, Chief Financial Officer of InflaRx



LEERINK Partners 7th Annual Global Healthcare Conference
Date: February 14-15, 2018
Presentation: Wed, 14th Feb 1:30 pm EST (7:30 pm CET)
Venue: New York, NY, USA
Presenter: Prof. Niels Riedemann, Chief Executive Officer of InflaRx

Live webcasts of the presentations will be provided at www.InflaRx.com through the "Events & Presentations" section on the "Investors" page. A replay of the presentations will be available from InflaRx's website following the conferences.

About InflaRx N.V.:

InflaRx (Nasdaq:IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and has offices in Jena and Munich, Germany. InflaRx is listed on the NASDAQ Global Select Market in the United States under the trading symbol "IFRX."

Contacts:
InflaRx N.V.

Prof. Dr. Niels C. Riedemann - CEO
Email: infoatinflarx.de
Tel: +49-3641-508180

MC Services AG
Katja Arnold, Andreas Jungfer
Email: inflarxatmc-services.eu
Tel: +49-89-210 2280



04.01.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


show this

Page: 1


Related Keywords:

[ServletException in:/common/ads/links.jsp] The absolute uri: http://java.sun.com/jstl/core cannot be resolved in either web.xml or the jar files deployed with this application'

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved